Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
FIBROGEN INC (FGEN)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/23/2023 |
4/A
| Conterno Enrique A (CEO) has filed a Form 4 on FIBROGEN INC|
Txns:
| Sold 19,489 shares
@ $20.1973, valued at
$393.6k
|
|
| 01/04/2023 |
4/A
| Chung Christine (SVP, China Operations) has filed a Form 4 on FIBROGEN INC|
Txns:
| Sold 2,595 shares
@ $15.79, valued at
$41k
|
|
| 01/04/2023 |
4/A
| Chung Christine (SVP, China Operations) has filed a Form 4 on FIBROGEN INC|
Txns:
| Paid exercise price by delivering 1,851 shares
@ $12.26, valued at
$22.7k
|
|
| 12/15/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 02/07/2019 |
4/A
| Ho Maykin (Director) has filed a Form 4 on FIBROGEN INC|
Txns:
| Granted 1,855 shares
@ $0
Granted 10,400 options to buy
@ $40.93, valued at
$425.7k
Granted 3,008 options to buy
@ $40.93, valued at
$123.1k
|
|
| 04/13/2018 |
4/A
| Neff Thomas B (CEO) has filed a Form 4 on FIBROGEN INC|
Txns:
| Exercised 24,844 options to buy
@ $4.025, valued at
$100k
|
|
|
|